Showing results (11-20 of 658) with videos related to
Sort By:
Pageof 66
Inflammatory Bowel Diseases|April 2, 2011
Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral centerRussell D Cohen, Jeffrey R Lewis, Hannah Turner, et al.Inflammatory Bowel Diseases|February 23, 2013
Natalizumab in Crohn's disease: results from a US tertiary inflammatory bowel disease centerAtsushi Sakuraba, Kian Keyashian, Chase Correia, et al.Nature Clinical Practice. Gastroenterology & Hepatology|November 3, 2005
Update on the etiology, pathogenesis and diagnosis of ulcerative colitisStephen B HanauerInflammatory Bowel Diseases|December 27, 2005
Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunitiesStephen B HanauerDigestive Diseases (Basel, Switzerland)|October 8, 2010
The role of biologics in ulcerative colitisStephen B HanauerReviews in Gastroenterological Disorders|March 30, 2007
Clinical perspectives in Crohn's disease. Turning traditional treatment strategies on their heads: current evidence for "step-up" versus "top-down"Stephen B HanauerBest Practice & Research. Clinical Gastroenterology|March 6, 2003
Crohn's disease: step up or top down therapyStephen B HanauerDigestive Diseases (Basel, Switzerland)|March 17, 2016
Oral or Topical 5-ASA in Ulcerative ColitisStephen B HanauerGut|August 19, 2007
Risks and benefits of combining immunosuppressives and biological agents in inflammatory bowel disease: is the synergy worth the risk?Stephen B HanauerReviews in Gastroenterological Disorders|May 15, 2008
The role of loperamide in gastrointestinal disordersStephen B HanauerPageof 66